- Home
- LCID vs BHVN Comparison
LCID vs BHVN Comparison
Compare LCID & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCID
- BHVN
- Stock Information
- Founded
- LCID 2007
- BHVN 2013
- Country
- LCID United States
- BHVN United States
- Employees
- LCID N/A
- BHVN N/A
- Industry
- LCID Auto Manufacturing
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- LCID Consumer Discretionary
- BHVN Health Care
- Exchange
- LCID Nasdaq
- BHVN Nasdaq
- Market Cap
- LCID 5.8B
- BHVN 5.4B
- IPO Year
- LCID N/A
- BHVN 2017
- Fundamental
- Price
- LCID $2.01
- BHVN $44.39
- Analyst Decision
- LCID Hold
- BHVN Strong Buy
- Analyst Count
- LCID 10
- BHVN 13
- Target Price
- LCID $3.43
- BHVN $63.42
- AVG Volume (30 Days)
- LCID 66.1M
- BHVN 725.9K
- Earning Date
- LCID 11-07-2024
- BHVN 11-12-2024
- Dividend Yield
- LCID N/A
- BHVN N/A
- EPS Growth
- LCID N/A
- BHVN N/A
- EPS
- LCID N/A
- BHVN N/A
- Revenue
- LCID $730,510,000.00
- BHVN N/A
- Revenue This Year
- LCID $40.55
- BHVN N/A
- Revenue Next Year
- LCID $96.14
- BHVN $179.00
- P/E Ratio
- LCID N/A
- BHVN N/A
- Revenue Growth
- LCID 4.98
- BHVN N/A
- 52 Week Low
- LCID $1.93
- BHVN $26.80
- 52 Week High
- LCID $5.31
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- LCID 28.13
- BHVN 33.48
- Support Level
- LCID $2.12
- BHVN $51.80
- Resistance Level
- LCID $2.33
- BHVN $54.53
- Average True Range (ATR)
- LCID 0.15
- BHVN 2.42
- MACD
- LCID 0.01
- BHVN -0.92
- Stochastic Oscillator
- LCID 12.90
- BHVN 9.80
About LCID Lucid Group Inc.
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.